Modified KSA and Uses Thereof
AssigneesAventis Pasteur Limited, Therion Biologics Corporation
InventorsNeil Berinstein, James Tartaglia, Mark Parrington, Dennis Panicali, Linda Gritz
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
Claims21
1-39. (canceled)
An expression vector useful for immunizing a host comprising nucleic acid sequences encoding modified KSA.
An isolated DNA molecule encoding SEQ ID NO.:
- 15.
An expression vector comprising SEQ ID NO.:
- 4 and p53 as shown in SEQ ID NO.:
- 2.
Dependencies are inferred from the claim text.